
1. Int J Environ Res Public Health. 2021 Oct 11;18(20). pii: 10644. doi:
10.3390/ijerph182010644.

A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2
in West-Mexico during COVID-19 Pandemic 2020.

Viera-Segura O(1), Vega-Magaña N(1)(2), García-Chagollán M(2), Peña-Rodríguez
M(1)(3), Muñoz-Sánchez G(4), Carranza-Aranda AS(4), Llamas-Covarrubias IM(5),
Ramos-Solano M(6), Mora-Mora J(1)(7), Díaz-Palomera CD(1)(8), León GE(1),
Zepeda-Nuño JS(3), Santillán-López E(4), García-Arellano S(2), Hernández-Silva
CD(4), Zerpa-Hernandez DA(2)(4), Muñoz-Rios G(1)(9), Rodríguez-Sanabria JS(8),
Muñoz-Valle JF(2).

Author information: 
(1)Laboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes,
Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la
Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
(2)Instituto de Investigación de Ciencias Biomédicas, Centro Universitario de
Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
(3)Centro de Investigación y Diagnóstico de Patologia, Departamento de
Microbiología y Patología, Centro Universitario de Ciencias de la Salud,
Universidad de Guadalajara, Guadalajara 44340, Mexico.
(4)Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la
Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
(5)Departamento de Biología Molecular y Genómica, Centro Universitario de
Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, CP,
Mexico.
(6)INICIA, CUCS Universidad de Guadalajara, Guadalajara 44340, Mexico.
(7)Maestría en Ciencias Médicas, Universidad de Colima, Colima 28040, Mexico.
(8)Doctorado en Ciencias en Biología Molecular en Medicina, Centro Universitario 
de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
(9)Doctorado en Ciencias Médicas, Universidad de Colima, Colima 280440, Mexico.

This study aimed to summarize the epidemiological and clinical characteristics of
COVID-19 from Western Mexico people during 2020. A retrospective analysis from an
electronic database of people visiting a sentinel center for molecular SARS-CoV-2
confirmatory diagnosis by RT-PCR from April to December 2020 was carried out for 
epidemiological and clinical description of COVID-19. Out of 23,211 patients
evaluated, 6918 (29.8%) were confirmed for SARS-CoV-2 infection (mean age 38.5 ± 
13.99), mostly females (53.8%). Comorbidities, such as diabetes (34.7%), obesity 
(31.15%), and hypertension (31.8%), presented an increased odds OR = 1.27, CI =
1.14-1.41; OR = 1.08, CI = 1.01-1.16; and OR = 1.09, CI = 0.99-1.19,
respectively, for viral-infection. Moreover, fever, headache, and dry cough were 
the most frequent symptoms. No infection difference among sex was found. Those
patients >60 years old were prone to COVID-19 severity (OR = 3.59, CI =
2.10-6.14), evaluated by the number of manifested symptoms, increasing with age. 
In conclusion, a high SARS-CoV-2 prevalence was found in Western Mexico.
Comorbidities were frequent in infected people; nevertheless, no association with
disease outcomes was observed, in contrast with the highest disease severity risk
found in older patients; however, continuous monitoring should be carried since
comorbidities have been reported as aggravating factors. This study can help the 
health officials for the elaboration of planning efforts of the disease
management and others in the future.

DOI: 10.3390/ijerph182010644 
PMCID: PMC8535709
PMID: 34682388  [Indexed for MEDLINE]

